Cargando…
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies
Advances in biotechnology have enabled us to assay human tissue and cells to a depth and resolution that was never possible before, redefining what we know as the “biomarker”, and how we define a “disease”. This comes along with the shift of focus from a “one-drug-fits-all” to a “personalized approa...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143954/ https://www.ncbi.nlm.nih.gov/pubmed/35629092 http://dx.doi.org/10.3390/jpm12050669 |